Tanager Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$732K Buy
610
+51
+9% +$52.1K 0.06% 75
2026
Q1
$514K Buy
559
+164
+42% +$166K 0.05% 81
2025
Q4
$424K Buy
395
+10
+3% +$9.56K 0.04% 89
2025
Q3
$294K Buy
385
+105
+38% +$78.1K 0.03% 102
2025
Q2
$218K Sell
280
-34
-11% -$26.4K 0.03% 112
2025
Q1
$259K Buy
+314
New +$261K 0.03% 101

Other funds holding LLY

Tanager Wealth Management's LLY Position: Q2 2026 in Review

Tanager Wealth Management increased its Eli Lilly (LLY) stake by 9.1% in Q2 2026, buying an estimated $52.1K and bringing the position to 610 shares worth $732K. The position accounts for 0.06% of the portfolio, ranked #75.

Tanager Wealth Management first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 1,654 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Tanager Wealth Management held 610 shares of Eli Lilly worth $732K as of Q2 2026.
  • Tanager Wealth Management bought 51 Eli Lilly shares in Q2 2026, an estimated $52.1K.
  • Eli Lilly made up 0.06% of Tanager Wealth Management's portfolio in Q2 2026, its #75 holding.
  • Tanager Wealth Management first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 1,654 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Tanager Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.